Stanford's HAI workshop gathered experts to address outdated AI healthcare regulations, focusing on clinical support, enterprise tools, and patient applications.
Mila and Sorintellis partner to use AI for optimising decision-making in clinical drug development, aiming to accelerate access to new therapies.
